Search for: "BRISTOL-MYERS SQUIBB COMPANY" Results 161 - 180 of 351
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
7 Sep 2016, 12:29 pm by Jim Higgins
The antipsychotic drug Abilify, also known as aripiprazole, is manufactured by Bristol-Myers Squibb Co. and Otsuka Pharmaceutical Co. [read post]
24 May 2017, 7:38 am by Robert Kraft
Bristol-Myers Squibb and Otsuka began marketing the drug in the US in 2002. [read post]
7 Aug 2012, 10:06 am by The Docket Navigator
Bristol-Myers Squibb Company, 1-12-cv-00394 (DED August 3, 2012, Order) (MDL Panel). [read post]
15 Aug 2017, 3:02 am by Walter Olson
Those days may be over” following the high court’s decision in Bristol-Myers Squibb [Margaret Cronin Fisk and Jef Feeley, Bloomberg] More: Multidistrict litigation sought in more patent cases [Amanda Bronstad, Texas Lawyer] Tags: Eastern District of Texas, forum shopping, Missouri, patent litigation, Supreme Court After SCOTUS rulings, less forum-shopping is a post from Overlawyered - Chronicling the high cost of our legal system [read post]
8 Oct 2020, 9:45 am by Patrick A. Malone
The prescription medications targeted by the lawmakers included “Celgene and Bristol Myers Squibb’s Revlimid cancer treatment, which saw its price hiked 23 times since 2005, and Teva’s multiple sclerosis drug Copaxone, which went up in price 27 times since 2007,” reported the independent, nonpartisan Kaiser Health News service. [read post]
19 Jan 2017, 1:07 pm by Amy Howe
Today’s grant comes in Bristol-Myers Squibb Co. v. [read post]
12 Apr 2017, 2:22 pm by Tom Lamb
An Observational Study Compared Myocardial Infarction / Heart Attack Risks As Between The Use Of Newer Blood Thinners And The Use Of Warfarin   (Posted by Tom Lamb at DrugInjuryWatch.com)   In the US, there are currently four direct-acting oral anticoagulants (DOACs), a relatively new class of blood thinners, approved for the prevention of stroke in patients with atrial fibrillation (AF): Pradaxa (dabigatran) -- approved by FDA in 2010 -- Boehringer Ingelheim Pharmaceuticals Xarelto… [read post]
1 Jul 2010, 1:32 pm by Richard Renner
Grassley letters are available in the continuation of this blog entryBelow are links to the letters sent by Grassley to: Abbott Laboratories Amgen AstraZeneca Pharmaceuticals Boehringer Bristol-Myers Squibb Company Eisai Corporation of America Eli Lilly and Company Forest Laboratories GlaxoSmithKline Hoffman-La Roche Inc. [read post]
13 Dec 2006, 4:41 am
The revised guidelines follow criticism that the tactics used in recent years against companies like the drug maker Bristol-Myers Squibb and the accounting firm KPMG were coercive and unconstitutional. they are being made at a time when companies are seeking — and receiving — greater protection from criminal and regulatory scrutiny. [read post]
4 Aug 2016, 9:24 am by Neumann Law Group
It is Bristol-Myers Squibb’s top-selling drug; it earned the pharmaceutical company $6.4 billion in 2013. [read post]
4 Aug 2016, 9:24 am by Neumann Law Group
It is Bristol-Myers Squibb’s top-selling drug; it earned the pharmaceutical company $6.4 billion in 2013. [read post]
Following the passage of the bylaw deadline, Icahn sought to nominate candidates for election to Amylin's board of directors in the wake of his learning of Amylin's recent rejection of an unsolicited takeover proposal by Bristol-Myers Squibb Co. [read post]
17 Jul 2008, 8:34 pm
In addition to Fed Ex, other companies that, following my shareholder proposals, agreed to amend their bylaws to incorporate pill-limiting provisions are JCPenney, Safeway, CVS Caremark, Disney, and Bristol-Myers Squibb. [read post]
28 Jun 2009, 6:17 pm
  This brought to mind the  Tequin recall by Bristol-Myers Squibb (BMS) in April 2006. [read post]
9 Jun 2014, 7:43 am by AmericanConferenceInstitute
Companies confirmed to speak to date include:  Amgen ■ Asuragen ■ Avanir Pharmaceuticals ■ Bayer ■ Biocryst Pharmaceuticals ■ Biogen Idec ■ Blueprint Medicines ■Bristol Myers Squibb■ Covidien ■ Edwards Lifesciences ■ Eisai Inc ■ Endo Pharmaceuticals ■ Ipsen… [read post]
28 Jul 2009, 1:11 pm
Some of the lawyers come from impressive backgrounds, including a former senior patent attorney at Bristol-Myers Squibb and a venture capitalist who worked at GE Asset Management. [read post]
24 Jan 2007, 9:59 pm
It was also recently reported that Lek D.D., a subsidiary of Sandoz, filed a complaint for patent infringement against Bristol-Myers Squibb and Watson Pharmaceuticals relating to BMS's Pravachol (pravastatin sodium). [read post]